HeartSciences (HSCS) has secured a patent from the European Patent Office for its "Electrocardiogram-Based Assessment of Diastolic Function" technology, the healthcare information technology company said Thursday.

The patent, effective April 29, covers machine-learning models and methods that estimate echocardiogram parameters for diastolic function using patient data and provides coverage in 19 European countries, the company said.

Shares of HeartSciences were down 2.4% in early Thursday trading.

Price: 1.84, Change: -0.04, Percent Change: -2.39